Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Asset Writedowns and Impairment (2021 - 2025)

GoHealth's Asset Writedowns and Impairment history spans 4 years, with the latest figure at $259.2 million for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $259.2 million; the TTM value through Sep 2025 reached $260.0 million, up 1999600.0%, while the annual FY2023 figure was $2.7 million, 89.33% down from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $259.2 million at GoHealth, up from $100000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $259.2 million in Q3 2025 and bottomed at -$45000.0 in Q4 2022.
  • The 4-year median for Asset Writedowns and Impairment is $222500.0 (2022), against an average of $26.4 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 128.89% in 2023 against a maximum downside of 103.77% in 2023.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at -$38000.0 in 2021, then decreased by 18.42% to -$45000.0 in 2022, then skyrocketed by 128.89% to $13000.0 in 2023, then surged by 1993369.23% to $259.2 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Asset Writedowns and Impairment are $259.2 million (Q3 2025), $100000.0 (Q2 2025), and $710000.0 (Q1 2025).